Subscribe to Newsletter
Diagnostics Genetics and epigenetics

Introducing the only true end-to-end NGS workflow

sponsored by Thermo Scientific

Available On-Demand

November 23, 2021

Whilst many NGS workflows are advertised as “end to end”, we believe that the Ion Torrent™ Genexus™ System and assay menu represents the only true end-to-end solution at the market. 2 instruments, 1 software and assays, all from one supplier will enable you go from biological specimen to report in as little as 1 day, involving only 20 min hand on time.

In this webinar we will introduce 3 laboratories who have experience with this solution. They will explain how and why they decided to use it and share their opinion on the value of true end-to-end NGS solution In addition, Jon Sherlock, director of product manager at Thermo Fisher Scientific, will outline the company’s plans for making these products compliant with IVDR.

Learning Objectives:

  • Hear experience from different laboratories using Ion Torrent Genexus System and Oncomine Precision Assay
  • Learn about Thermo Fisher Scientific plan for IVDR transition in 2022
  • Have a chance to ask questions and get answers live concerning both topics

Available On-Demand

Visit our Webinar Hub

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Related Application Notes
Evaluation of cell-free fetal DNA to determine fetal RhD status

| Contributed by Revvity

Preventing Bias in scRNAseq Performed on Solid Tumors

| Contributed by Revvity

Enabling Efficient, Cost-effective Sequencing of the Human Whole Exome

| Contributed by Revvity

Related Product Profile
Diagnostics Genetics and epigenetics
QIAseq® Pan Cancer Multimodal cuts user interventions by 50%

| Contributed by QIAGEN

Most Popular
Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine